ArticleERJ open research2025
Pneumonia-specific plasma metabolite profiles among patients hospitalised with infection in Southeast Asia.
Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging Ancestry-Stratified Bias in Pharmacogenomics AI: Toward Metabolomics-Inclusive Multi-Omics Precision Medicine.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Background: Community-acquired pneumonia (CAP) is a major public health threat globally but is understudied in regions with the highest burden. The host immune response during infection may differ based on the site of infection. We hypothesised that analysis of the plasma metabolome in patients hospitalised with suspected infection could identify host response pathways specific to CAP. Methods: We analysed the plasma metabolomes of adults admitted to a tertiary care hospital in northeastern Thailand with suspected community-acquired infection. Multivariable linear regression was performed for differential metabolite analyses and the global test was used for pathway analysis comparing patients with CAP Results: 841 metabolites from 107 CAP patients and 152 non-CAP infected patients were analysed. 52 metabolites were differentially abundant between the CAP and non-CAP groups. CAP was characterised by increased metabolites involved in polyamine metabolism and decreased metabolites involved in lipid pathways. 13 pathways were differentially enriched between the CAP and non-CAP groups, consistent with individual metabolite analyses. 40 metabolites and four pathways were associated with CAP-specific mortality. A four-metabolite signature predicted 28-day mortality in CAP (area under the curve 0.79, 95% CI 0.62-0.97). Conclusion: In a rural tropical setting, CAP induced a distinct metabolomic state compared to non-CAP presentations of infection that may reflect the activation of select host immune responses.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.